You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Taxane Refractory

Showing 26 - 50 of 9,237
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Peripheral Neuropathy Due to Chemo Trial in Cairo (Losartan)

Recruiting
  • Peripheral Neuropathy Due to Chemotherapy
  • Cairo, Egypt
    Breast Cancer Comprehensive Center of the National Cancer Instit
Nov 26, 2023

Predictive fActors for toleraNce to Taxane Based CHemotherapy In

Completed
  • Elderly Patients
  • Metastatic Prostate Cancer
  • Taxane chemotherapy
  • Florence, Italy
    AOU Careggi Radiation Oncology Unit
Jul 21, 2022

Metastatic Castration-resistant Prostate Cancer Trial (Darolutamide, Docetaxel or cabazitaxel)

Not yet recruiting
  • Metastatic Castration-resistant Prostate Cancer
  • (no location specified)
Feb 28, 2023

Breast Cancer Trial (Investigational drug: Recombinant Anti-HER2 Humanized Monoclonal Antibody - Monomethyl Auristatin F

Not yet recruiting
  • Breast Cancer
  • Investigational drug: Recombinant Anti-HER2 Humanized Monoclonal Antibody - Monomethyl Auristatin F Conjugates for Injection (FS-1502)
  • Control drug: Trastuzumab emtansine (Kadcyla, T-DM1)
  • (no location specified)
Feb 22, 2023

Malignant Solid Tumor Trial (Biospecimen Collection, Cryocompression Therapy, Pneumatic Compression Therapy)

Not yet recruiting
  • Malignant Solid Neoplasm
  • Biospecimen Collection
  • +4 more
  • (no location specified)
Nov 30, 2022

Metastatic Breast Cancer Trial in Worldwide (Trastuzumab Emtansine, Atezolizumab, Placebo)

Recruiting
  • Metastatic Breast Cancer
  • Trastuzumab Emtansine
  • +2 more
  • Fountain Valley, California
  • +139 more
Aug 17, 2022

Metastatic Castration-Resistant Prostate Cancer (mCRPC) Trial ([177Lu]Lu-PSMA-617, ARDT, [68Ga]Ga-PSMA-11)

Not yet recruiting
  • Metastatic Castration-Resistant Prostate Cancer (mCRPC)
  • (no location specified)
Jan 23, 2023

Breast Cancer, Taxane-Induced Peripheral Neuropathy Trial in United States (Real Acupuncture, Sham Acupuncture)

Recruiting
  • Breast Cancer
  • Taxane-Induced Peripheral Neuropathy
  • Real Acupuncture
  • Sham Acupuncture
  • Basking Ridge, New Jersey
  • +6 more
Jul 11, 2022

TNBC - Triple-Negative Breast Cancer Trial (epirubicin,cyclophosphamide,paclitaxel,Carrelizumab,

Not yet recruiting
  • TNBC - Triple-Negative Breast Cancer
  • (no location specified)
May 8, 2023

Chemo-induced Peripheral Neuropathy Trial in New York (Cannabinoids)

Terminated
Has Results
  • Chemotherapy-induced Peripheral Neuropathy
  • New York, New York
    1051 Riverside Drive
Jan 3, 2023

Breast Cancer Trial in Worldwide (Trastuzumab, MYL- 1401O, Paclitaxel)

Completed
Has Results
  • Breast Cancer
  • Trastuzumab
  • +3 more
  • Barretos, Brazil
  • +92 more
Feb 10, 2022

Chemotherapeutic Toxicity Trial (Home Based Walking Program)

Not yet recruiting
  • Chemotherapeutic Toxicity
  • Home Based Walking Program
  • (no location specified)
Aug 28, 2023

Skin Angiosarcoma, Skin Radiation-Related Angiosarcoma, Visceral Angiosarcoma Trial in Guam, United States (drug, biological,

Active, not recruiting
  • Skin Angiosarcoma
  • +2 more
  • Cabozantinib S-malate
  • +4 more
  • Phoenix, Arizona
  • +171 more
Dec 28, 2022

Metastatic Breast Cancer, Breast Carcinoma Trial in New York (ACY-1215, Nab-paclitaxel)

Completed
  • Metastatic Breast Cancer
  • Breast Carcinoma
  • New York, New York
    Columbia Irving University Medical Center
Jan 5, 2021

HER2-Positive, Unresectable and/or Metastatic Breast Cancer Subjects Previously Treated With Trastuzumab and Taxane Trial in

Recruiting
  • HER2-Positive, Unresectable and/or Metastatic Breast Cancer Subjects Previously Treated With Trastuzumab and Taxane
  • SHR-A1811
  • Pyrotinib in combination with Capecitabine.
  • Guangzhou, Guangdong, China
    Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University
Aug 8, 2022

Breast Cancer Trial in Los Angeles, Portland (Ipilimumab, Nivolumab, Core Biopsy/Cryoablation)

Recruiting
  • Breast Cancer
  • Los Angeles, California
  • +2 more
Sep 27, 2022

Solid Tumor Trial (IN10018, Nab-paclitaxel, Tislelizumab)

Not yet recruiting
  • Solid Tumor
  • (no location specified)
Aug 1, 2023

Breast Cancer Trial (Epidiferphane, Taxane Chemotherapy)

Recruiting
  • Breast Cancer
  • Gainesville, Florida
    University of Florida
Jan 4, 2023

Breast Tumors, Malignant Tumor of the Breast Trial in Multiple Locations (Trastuzumab, Pertuzumab, Vinorelbine, Paclitaxel,

Terminated
  • Breast Neoplasms
  • Malignant Tumor of the Breast
  • Multiple Locations, Texas
    19 Sites
Nov 29, 2022

Advanced or Metastatic Esophageal Squamous Cell Carcinoma Trial in Worldwide (RO7121661, RO7247669, Nivolumab)

Recruiting
  • Advanced or Metastatic Esophageal Squamous Cell Carcinoma
  • Buenos Aires, Argentina
  • +79 more
Aug 3, 2022

Chemo-induced Peripheral Neuropathy Trial (Compression therapy using surgical gloves)

Not yet recruiting
  • Chemotherapy-induced Peripheral Neuropathy
  • Compression therapy using surgical gloves
  • (no location specified)
Mar 20, 2023

Neuropathic Pain Trial in Richmond (Ergocalciferol Capsules, Cholecalciferol Capsules)

Not yet recruiting
  • Neuropathic Pain
  • Ergocalciferol Capsules
  • Cholecalciferol Capsules
  • Richmond, Virginia
    Virginia Commonwealth University
Jun 16, 2022

Histologically-proven and Radiologically-confirmed Solid Tumors Trial in Italy, New Zealand (ASA404)

Terminated
  • Histologically-proven and Radiologically-confirmed Solid Tumors
  • Ancona, AN, Italy
  • +3 more
Dec 6, 2020

Ovarian Cancer Trial in Worldwide (Olaparib, Placebo)

Completed
  • Ovarian Cancer
  • Graz, Austria
  • +162 more
Aug 1, 2022

Metastatic Breast Cancer Trial in Spain (Ipatasertib, Trastuzumab, Pertuzumab)

Recruiting
  • Metastatic Breast Cancer
  • Badalona, Barcelona, Spain
  • +9 more
Oct 24, 2022